Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for HIV-associated lipodystrophy
NL-OMON25981Active, not recruiting
- Sponsor
- Amsterdam UMC
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in HIV-associated lipodystrophy (HALS) and human immunodeficiency virus infection (HIV) comparing Rosiglitazone with Placebo (2 arms). Primary endpoints: Insulin sensitivity and Fat distribution. Started Nov 2003; status: active, not recruiting.
02
Drugs
rosiglitazone
03
Conditions
HIV-associated lipodystrophy (HALS)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON25981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25981.